Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NCS Multistage Holdings (NCSM) Capital Expenditures (2016 - 2025)

NCS Multistage Holdings (NCSM) has 10 years of Capital Expenditures data on record, last reported at $225000.0 in Q4 2025.

  • For Q4 2025, Capital Expenditures changed 0.44% year-over-year to $225000.0; the TTM value through Dec 2025 reached $1.2 million, down 8.25%, while the annual FY2025 figure was $1.2 million, 8.25% down from the prior year.
  • Capital Expenditures reached $225000.0 in Q4 2025 per NCSM's latest filing, down from $231000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $957000.0 in Q4 2022 and bottomed at -$138000.0 in Q2 2022.
  • Average Capital Expenditures over 5 years is $296100.0, with a median of $230500.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: tumbled 160.0% in 2022, then skyrocketed 2413.64% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $171000.0 in 2021, then skyrocketed by 459.65% to $957000.0 in 2022, then tumbled by 81.4% to $178000.0 in 2023, then increased by 26.97% to $226000.0 in 2024, then decreased by 0.44% to $225000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $225000.0 in Q4 2025, $231000.0 in Q3 2025, and $281000.0 in Q2 2025.